Personal CFO Solutions’s Evofem Biosciences, Inc. Common Stock EVFM Stock Holding History

Personal CFO Solutions’s Portfolio EVFM Stock Details EVFM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-1,059	Closed	-$5K	–	513
2022 Q1	$5K	Hold	1,059	–	–	﹤0.01%	470
2021 Q4	$6K	Hold	1,059	–	–	﹤0.01%	475
2021 Q3	$12K	Hold	1,059	–	–	﹤0.01%	451
2021 Q2	$18K	Buy	1,059 +333	+46%	+$6.31K	﹤0.01%	437
2021 Q1	$19K	Buy	+726	New	+$33K	﹤0.01%	406
2020 Q4	–	Sell	-859	Closed	–	–	411
2020 Q3	$0	Hold	859	–	–	﹤0.01%	349
2020 Q2	$36K	Buy	+859	New	+$57.9K	0.01%	307

Other funds holding EVFM

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

FWSM

First Wilshire Securities Management Pasadena, California $444M AUM 42.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Personal CFO Solutions's EVFM Position: Q2 2022 in Review

Personal CFO Solutions sold out of Evofem Biosciences, Inc. Common Stock (EVFM) in Q2 2022, closing a stake of 1,059 shares — an estimated $5K sold.

Personal CFO Solutions first reported a position in EVFM in Q2 2020 and held it in 7 quarters. The position peaked at $36K in Q2 2020. 44 funds tracked by Wall St. Rank hold EVFM as of Q2 2022.

Personal CFO Solutions reported no remaining Evofem Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
Personal CFO Solutions sold 1,059 Evofem Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $5K.
Personal CFO Solutions first reported a position in Evofem Biosciences, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
Personal CFO Solutions's Evofem Biosciences, Inc. Common Stock position peaked at $36K in Q2 2020.
44 funds tracked by Wall St. Rank held Evofem Biosciences, Inc. Common Stock as of Q2 2022.

Based on Personal CFO Solutions's 13F filing for Q2 2022, filed 5 Aug 2022.